Back to Search
Start Over
Immunological targeting of cytomegalovirus for glioblastoma therapy.
- Source :
-
OncoImmunology . Jun2014, Vol. 3 Issue 6, pN.PAG-N.PAG. 1p. - Publication Year :
- 2014
-
Abstract
- Human cytomegalovirus (CMV) is purportedly present in glioblastoma (GBM) while absent from the normal brain, making CMV antigens potentially ideal immunological anti-GBM targets. We recently demonstrated that patient-derived CMV pp65-specific T cells are capable of recognizing and killing autologous GBM tumor cells. This data supports CMV antigen-directed immunotherapies against GBM. [ABSTRACT FROM PUBLISHER]
Details
- Language :
- English
- ISSN :
- 21624011
- Volume :
- 3
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- OncoImmunology
- Publication Type :
- Academic Journal
- Accession number :
- 101348145
- Full Text :
- https://doi.org/10.4161/onci.29289